Tingyi Pharmaceutical-B Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies in Chronic Hepatitis B
Jul 03, 2026 08:58
CST Updated
08:58
Brii Biosciences
Innovative Drug Research and Development Service Provider
Premium VIP Investment Research Content
This content is available to subscribers only.
VIP